MedKoo Cat#: 596869 | Name: Argininamide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Argininamide is used as a model compound in studies of the physicochemical characteristic of ligand binding DNA aptamers and their potential development as fluorescent aptasensors.

Chemical Structure

Argininamide
CAS#2788-83-2

Theoretical Analysis

MedKoo Cat#: 596869

Name: Argininamide

CAS#: 2788-83-2

Chemical Formula: C6H15N5O

Exact Mass: 173.1277

Molecular Weight: 173.22

Elemental Analysis: C, 41.60; H, 8.73; N, 40.43; O, 9.24

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Argininamide; L-Arginamide; L-Argininamide; L-Arginine amide;
IUPAC/Chemical Name
(S)-2-amino-5-guanidinopentanamide
InChi Key
ULEBESPCVWBNIF-BYPYZUCNSA-N
InChi Code
InChI=1S/C6H15N5O/c7-4(5(8)12)2-1-3-11-6(9)10/h4H,1-3,7H2,(H2,8,12)(H4,9,10,11)/t4-/m0/s1
SMILES Code
O=C(N)[C@@H](N)CCCNC(N)=N
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 173.22 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Cai T, Zhou J, Jiang Y, Xie K, Fang D, Qi H, Wu Z. Gas-phase intramolecular hydroxyl-amino exchange of protonated arginine and verified by the synthetic intermediate compound. J Mass Spectrom. 2018 May 29. doi: 10.1002/jms.4208. [Epub ahead of print] PubMed PMID: 29813178. 2: Gülbakan B, Barylyuk K, Schneider P, Pillong M, Schneider G, Zenobi R. Native Electrospray Ionization Mass Spectrometry Reveals Multiple Facets of Aptamer-Ligand Interactions: From Mechanism to Binding Constants. J Am Chem Soc. 2018 Jun 1. doi: 10.1021/jacs.7b13044. [Epub ahead of print] PubMed PMID: 29733584. 3: Bahamondes C, Wilson L, Guzmán F, Illanes A. Mathematical determination of kinetic parameters for assessing the effect of the organic solvent on the selectivity of peptide synthesis with immobilized α-chymotrypsin. J Biosci Bioeng. 2017 Dec;124(6):618-622. doi: 10.1016/j.jbiosc.2017.06.017. Epub 2017 Aug 25. PubMed PMID: 28847579. 4: Perazzo J, Lima C, Heras M, Bardají E, Lopes-Ferreira M, Castanho M. Neuropeptide Kyotorphin Impacts on Lipopolysaccharide-Induced Glucocorticoid-Mediated Inflammatory Response. A Molecular Link to Nociception, Neuroprotection, and Anti-Inflammatory Action. ACS Chem Neurosci. 2017 Aug 16;8(8):1663-1667. doi: 10.1021/acschemneuro.7b00007. Epub 2017 May 9. PubMed PMID: 28472878. 5: Keller M, Maschauer S, Brennauer A, Tripal P, Koglin N, Dittrich R, Bernhardt G, Kuwert T, Wester HJ, Buschauer A, Prante O. Prototypic (18)F-Labeled Argininamide-Type Neuropeptide Y Y(1)R Antagonists as Tracers for PET Imaging of Mammary Carcinoma. ACS Med Chem Lett. 2017 Feb 21;8(3):304-309. doi: 10.1021/acsmedchemlett.6b00467. eCollection 2017 Mar 9. PubMed PMID: 28337321; PubMed Central PMCID: PMC5346983. 6: Raikou V, Varvaresou A, Panderi I, Papageorgiou E. The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. A prospective, randomized controlled study. J Cosmet Dermatol. 2017 Jun;16(2):271-278. doi: 10.1111/jocd.12314. Epub 2017 Feb 2. PubMed PMID: 28150423. 7: Bahamondes C, Wilson L, Bernal C, Illanes A, Álvaro G, Guzmán F. Synthesis of the kyotorphin precursor benzoyl-L-tyrosine-L-argininamide with immobilized α-chymotrypsin in sequential batch with enzyme reactivation. Biotechnol Prog. 2016 Jan-Feb;32(1):54-9. doi: 10.1002/btpr.2187. Epub 2015 Nov 6. PubMed PMID: 26488135. 8: Keller M, Weiss S, Hutzler C, Kuhn KK, Mollereau C, Dukorn S, Schindler L, Bernhardt G, König B, Buschauer A. N(ω)-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([(3)H]UR-MK299) with Extended Residence Time. J Med Chem. 2015 Nov 25;58(22):8834-49. doi: 10.1021/acs.jmedchem.5b00925. Epub 2015 Nov 4. PubMed PMID: 26466164. 9: Keller M, Schindler L, Bernhardt G, Buschauer A. Toward Labeled Argininamide-Type NPY Y1 Receptor Antagonists: Identification of a Favorable Propionylation Site in BIBO3304. Arch Pharm (Weinheim). 2015 Jun;348(6):390-8. doi: 10.1002/ardp.201400427. Epub 2015 Apr 17. PubMed PMID: 25884646. 10: Albada HB, Golub E, Willner I. Computational docking simulations of a DNA-aptamer for argininamide and related ligands. J Comput Aided Mol Des. 2015 Jul;29(7):643-54. doi: 10.1007/s10822-015-9844-5. Epub 2015 Apr 16. PubMed PMID: 25877490. 11: Hoppel M, Reznicek G, Kählig H, Kotisch H, Resch GP, Valenta C. Topical delivery of acetyl hexapeptide-8 from different emulsions: influence of emulsion composition and internal structure. Eur J Pharm Sci. 2015 Feb 20;68:27-35. doi: 10.1016/j.ejps.2014.12.006. Epub 2014 Dec 9. PubMed PMID: 25497319. 12: Sadatmousavi P, Kovalenko E, Chen P. Thermodynamic characterization of the interaction between a peptide-drug complex and serum proteins. Langmuir. 2014 Sep 23;30(37):11122-30. doi: 10.1021/la502422u. Epub 2014 Sep 10. PubMed PMID: 25166955. 13: Hojo K, Shinozaki N, Hidaka K, Tsuda Y, Fukumori Y, Ichikawa H, Wade JD. Aqueous microwave-assisted solid-phase peptide synthesis using Fmoc strategy. III: racemization studies and water-based synthesis of histidine-containing peptides. Amino Acids. 2014 Oct;46(10):2347-54. doi: 10.1007/s00726-014-1779-y. Epub 2014 Jun 26. PubMed PMID: 24965528. 14: Kraeling ME, Zhou W, Wang P, Ogunsola OA. In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutan Ocul Toxicol. 2015 Mar;34(1):46-52. doi: 10.3109/15569527.2014.894521. Epub 2014 Apr 22. PubMed PMID: 24754410. 15: Grosicki M, Latacz G, Szopa A, Cukier A, Kieć-Kononowicz K. The study of cellular cytotoxicity of argireline - an anti-aging peptide. Acta Biochim Pol. 2014;61(1):29-32. Epub 2014 Mar 17. PubMed PMID: 24644551. 16: Zhao Q, Zhang Z, Xu L, Xia T, Li N, Liu J, Fang X. Exonuclease I aided enzyme-linked aptamer assay for small-molecule detection. Anal Bioanal Chem. 2014 May;406(12):2949-55. doi: 10.1007/s00216-014-7705-z. Epub 2014 Mar 6. PubMed PMID: 24599422. 17: Sadatmousavi P, Chen P. Self/co-assembling peptide, EAR8-II, as a potential carrier for a hydrophobic anticancer drug pirarubicin (THP)--characterization and in-vitro delivery. Int J Mol Sci. 2013 Nov 26;14(12):23315-29. doi: 10.3390/ijms141223315. PubMed PMID: 24287908; PubMed Central PMCID: PMC3876047. 18: Severino B, Incisivo GM, Fiorino F, Bertolino A, Frecentese F, Barbato F, Manganelli S, Maggioni G, Capasso D, Caliendo G, Santagada V, Sorrentino R, Roviezzo F, Perissutti E. Identification of a pepducin acting as S1P3 receptor antagonist. J Pept Sci. 2013 Nov;19(11):717-24. doi: 10.1002/psc.2554. Epub 2013 Sep 20. PubMed PMID: 24133031. 19: Keller M, Kaske M, Holzammer T, Bernhardt G, Buschauer A. Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors. Bioorg Med Chem. 2013 Nov 1;21(21):6303-22. doi: 10.1016/j.bmc.2013.08.065. Epub 2013 Sep 8. PubMed PMID: 24074877. 20: Wunderlich CH, Huber RG, Spitzer R, Liedl KR, Kloiber K, Kreutz C. A novel paramagnetic relaxation enhancement tag for nucleic acids: a tool to study structure and dynamics of RNA. ACS Chem Biol. 2013 Dec 20;8(12):2697-706. doi: 10.1021/cb400589q. Epub 2013 Oct 4. PubMed PMID: 24053726; PubMed Central PMCID: PMC3870906.